Risk of progression following a negative biopsy in prostate cancer active surveillance

BACKGROUND: Currently, follow-up protocols are applied equally to men on active surveillance (AS) for prostate cancer (PCa) regardless of findings at their initial follow-up biopsy. To determine whether less intensive follow-up is suitable following negative biopsy findings, we assessed the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Beckmann, Kerri, Santaolalla, Aida, Sugimoto, Mikio, Carroll, Peter, Rubio, Jose, Villers, Arnauld, Bjartell, Anders, Morgan, Todd, Dasgupta, Prokar, Van Hemelrijck, Mieke, Elhage, Oussama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247354/
https://www.ncbi.nlm.nih.gov/pubmed/36008540
http://dx.doi.org/10.1038/s41391-022-00582-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247354/
https://www.ncbi.nlm.nih.gov/pubmed/36008540
http://dx.doi.org/10.1038/s41391-022-00582-x

Ejemplares similares